uniQure N.V. Deferred Income Tax Liabilities, Net
uniQure N.V. (QURE) had Deferred Income Tax Liabilities, Net of $7.80 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-05-05
- 2026-03-31: Deferred Income Tax Liabilities, Net $7.80M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $7.97M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $7.96M.
- 2025-06-30: Deferred Income Tax Liabilities, Net $7.96M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-03-31 | $7.80M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $7.97M 10-Q · filed 2026-05-05 |
| 2025-09-30 | $7.96M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $7.96M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $7.34M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $7.04M 10-K · filed 2026-03-02 |
| 2024-09-30 | $7.63M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $7.32M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $7.38M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $7.54M 10-K · filed 2025-02-27 |
| 2023-09-30 | $4.92M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $6.80M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $6.97M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $8.26M 10-K · filed 2024-02-28 |
| 2022-09-30 | $8.59M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $9.95M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $11.30M 10-Q · filed 2022-05-02 |
| 2021-12-31 | $12.91M 10-K · filed 2023-02-27 |
| 2021-09-30 | $13.14M 10-Q · filed 2021-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |